Is the Correction Over? Part 2
The good news is that the cannabis industry in North America is booming. Legal recreational sales in Canada are very healthy, with the only problem being a supply shortage—which will be alleviated in the months ahead. And legal continues...
Read More
Is the Correction Over?
Last Tuesday, the day before the opening of the legal commercial market for marijuana in Canada, I sent you an update that said, in part, “I believe the odds are that this will mark an intermediate-term top for many of stocks...
Read More
Eleven years ago, Sears stock was at all-time highs, a $23 billion company. Now the company is bankrupt, and the stock is almost at zero. What happened?!
Read More
October 17 Approaches!
First, I want to welcome all my new readers to the first issue of Cabot Marijuana Investor, the successor to the quarterly report that was Cabot’s Ten Best Marijuana stocks. When I started that report back in August 2017, I was about...
Read More
Eighteen months ago, Papa John's stock was trading at all-time highs. Thanks to a series of embarrassing missteps by its namesake CEO, it's down 46% since.
Read More
Once a high riser, the IHE biotech ETF has been stuck in the mud for two years. But that doesn't mean you should tune out the biopharma industry as a whole.
Read More
It was a rough week for the retail sector, but that doesn’t mean retailers no longer make good investment opportunities. Many of them still offer healthy share price returns in addition to regular dividend growth. Later in this article, I’ll tell you about I..
Read More
Would you lend a friend $100 if he promised to pay you back $99 within a year?
Read More
Google, with its mantra "Don't Be Evil," has never been totally comfortable in China, which employs an army of censors and spends monumental amounts of money to control Internet content.
Read More
